BVT Call 130 MRK 21.03.2025/ DE000VD9NXS7 /
8/9/2024 8:01:57 PM | Chg.0.000 | Bid8:01:57 PM | Ask8:01:57 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.280EUR | 0.00% | 0.280 Bid Size: 60,000 |
0.290 Ask Size: 60,000 |
Merck and Co Inc | 130.00 USD | 3/21/2025 | Call |
GlobeNewswire
6/11
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire
6/6
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire
5/28
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
5/23
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
5/16
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
5/8
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
4/24
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
4/15
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness